NetworkNewsBreaks

WednesdayOct 10, 2018 9:26 am

NetworkNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Unveils Four New Subsidiary Companies

Lexaria Bioscience (CSE: LXX) (OTCQX: LXRP) this morning announced the creation of four new wholly-owned subsidiary companies: Lexaria CanPharm Corp., a Canadian company that provides DehydraTECH technology and other enhancements to the global cannabis industry; Lexaria Nicotine Corp., a US company with a global license to offer DehydraTECH technology to the global nicotine and tobacco industries; Lexaria Hemp Corp., a US company globally licensed to provide DehydraTECH to the burgeoning hemp-based foods and supplements industries; and Lexaria Pharmaceutical Corp., a US company internationally authorized to license DehydraTECH to the pharmaceutical sector, including pain relief, vitamins, hormone treatments, central nervous system…

Continue Reading

TuesdayOct 09, 2018 3:12 pm

NetworkNewsBreaks – Why Golden Developing Solutions, Inc. (DVLP) is “One to Watch”

Golden Developing Solutions (OTCMKTS: DVLP) is an emerging leader in the cannabis and CBD industry that offers business services and products within the cannabis industry including online retail business for CBD, hemp oil and health & wellness related products. An article discussing the company and its recent acquisition of Where’s Weed reads: “As a rapidly growing community-based online resource for cannabis consumers with a host of user-friendly services, Where’s Weed offers a sophisticated mobile app with strong traction and powerful growth potential as the North American legal cannabis market continues to expand exponentially. WheresWeed.com has a large and expanding reach…

Continue Reading

TuesdayOct 09, 2018 3:05 pm

NetworkNewsBreaks – BLOCKStrain Technology Corp. (TSX.V: DNAX) (OTC: BKKSF) Technology Enables Consumers to Ensure Purchase of Safe, Quality-tested Products

BLOCKStrain Technology (TSX.V: DNAX) (OTC: BKKSF) is investing in technological means to offer the transparency desired by businesses and consumers within the cannabis pipeline amid recent lab testing concerns. Using its easily integrated BLOCKStrain platform, consumers are able to distinguish between high- and low-quality products. A recent article discussing the company reads: “BLOCKStrain’s proprietary technology will serve clients at both ends of the production pipeline and those in between. Growers want to know that their product is making it to market in good condition. Consumers want to know that the product they buy was manufactured by a company invested in…

Continue Reading

TuesdayOct 09, 2018 12:10 pm

NetworkNewsBreaks – Earth Science Tech, Inc. (ETST) Details Branding Strategy for Hygee Personal Feminine Health Test

Biotechnology company Earth Science Tech Inc. (OTCQB: ETST) this morning detailed its branding strategy for Hygee, a medical device designed for the detection of sexually transmitted infections (STIs) in women. Per the update, ETST intends to market Hygee on five continents by deploying a graphic identity that will speak directly to women alongside a product name that highlights the aim of the device. A play on the Greek word for “hygiene,” the name Hygee integrates intimacy, confidentiality and discretion. “From the name of the device to specifics of the logo, our branding strategy reflects the personal yet crucial nature of…

Continue Reading

TuesdayOct 09, 2018 12:01 pm

NetworkNewsBreaks – Global Payout, Inc. (GOHE) Reports Significant Rise in MTrac Platform Transactions with New Pin Debit System

Global Payout (OTC: GOHE), alongside wholly owned subsidiary MTrac Tech Corp., this morning announced that its new pin debit system that has been deployed and is now live in one of the initial merchants to sign on with MTrac has considerably increased the amount of transactions processed through the MTrac Platform. The new pin debit system developed by Cultivate Technologies furthers MTrac’s mission to deliver seamless merchant processing for high risk industries such as the cannabis sector. The company will continue to monitor the first live test case of the new MTrac Platform over the coming days and anticipates to…

Continue Reading

TuesdayOct 09, 2018 11:23 am

NetworkNewsBreaks – SinglePoint, Inc. (SING) Highlights Success of SingleCoin Bitcoin Wallet App following Launch of National TV Campaign

Technology and investment company SinglePoint, Inc. (OTCQB: SING) this morning announced that its recently launched bitcoin wallet application SingleCoin has surpassed 12,000 downloads and is continuing to experience strong demand on both Google Play and the Apple App Store. The milestone comes on the heels of SinglePoint’s launch of a national TV campaign featuring Kevin Harrington, an original Shark from ABC’s hit show ‘Shark Tank’ (http://nnw.fm/4pgFU). “This has been a huge success in our eyes. We plan to line up more air time for the commercial,” Wil Ralston, president of SinglePoint, stated in the news release. “As our user base…

Continue Reading

TuesdayOct 09, 2018 11:16 am

NetworkNewsBreaks – Marijuana Company of America Inc. (MCOA) Names Global Sales Director of hempSMART Subsidiary

Innovative hemp and cannabis corporation Marijuana Company of America (OTC: MCOA) this morning announced the appointment of Ian Harvey as the Global Sales Director of the company’s wholly-owned UK subsidiary hempSMART™, Ltd. As a seasoned veteran of the direct sales industry, Harvey has assisted in the development of numerous corporations around the world. Leveraging this experience, Harvey will oversee hempSMART’s launch of its network marketing program and industrial hemp derived cannabidiol (“CBD”) product line in Europe in January 2019, which will begin with the United Kingdom. “We are very excited to add Ian Harvey to our hempSMART team. Throughout my…

Continue Reading

TuesdayOct 09, 2018 10:34 am

NetworkNewsBreaks – American Premium Water Corp. (HIPH) Brings First Hydro-nano CBD Beverage to Market

American Premium Water (OTC: HIPH), based in Playa Vista, California, is a holding company that maintains a portfolio of subsidiaries, including LALPINA HYDRO, LALPINA HYDRO CBD, Gents, Worthy, and FashionCoinX. The company recently launched its CBD beverage, LALPINA Hydro CBD. The product is the first of its kind on the market, employing advanced hydro-nano technology which mixes hydro and encapsulates the CBD with nano technology. LALPINA turns the CBD molecule into a water-soluble compound which increases its bioavailability and delivery to the body’s cells and tissues, enabling up to 90 percent higher absorption rates than traditional CBD water. Raising the…

Continue Reading

TuesdayOct 09, 2018 10:08 am

NetworkNewsBreaks – BriaCell Therapeutics Corp. (TSX.V: BCT) (OTCQB: BCTXF) Initiates Patient Dosing in Combination Study of Bria-IMT

BriaCell Therapeutics Corp. (TSX.V: BCT) (OTCQB: BCTXF), an immuno-oncology focused biotechnology company with a proprietary targeted immunotherapy technology, this morning announced that it has initiated patient dosing in a phase I/IIa study of its lead clinical candidate, Bria-IMT, in combination with pembrolizumab [KEYTRUDA; manufactured by Merck & Co., Inc. (NYSE: MRK)] or ipilimumab [YERVOY; manufactured by Bristol-Myers Squibb Company (NYSE: BMY)]. “We believe that combination of Bria-IMT with immune checkpoint inhibitors should create even more potent anti-cancer immune responses, leading to our strategy of combination studies of Bria-IMT with KEYTRUDA or YERVOY,” Bill Williams, president and CEO of BriaCell, stated…

Continue Reading

TuesdayOct 09, 2018 9:28 am

NetworkNewsBreaks – CytoDyn Inc. (CYDY) Unveils Development Strategy for PCaTest, Nears Close of Proposed ProstaGene Asset Acquisition

CytoDyn Inc. (OTCQB: CYDY), a biotechnology company developing innovative treatments for multiple therapeutic indications, this morning detailed its strategy for completing the development of PCaTest, a novel gene-based prognostic test for prostate cancer developed by ProstaGene. Following the completion of its previously announced proposed acquisition of assets from ProstaGene, which is expected to close during the fourth quarter of 2018, CytoDyn intends to initiate a clinical study aimed at further demonstrating the superiority of the PCaTest, as compared with current genetic tests, in predicting outcomes of individuals with prostate cancer. Per the update, results are expected to be available within…

Continue Reading